TITLE

Melanoma, Nevogenesis, and Stem Cell Biology

AUTHOR(S)
Grichnik, James M
PUB. DATE
October 2008
SOURCE
Journal of Investigative Dermatology;Oct2008, Vol. 128 Issue 10, p2365
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
It is now well established that a subpopulation of tumor stem cells (TSCs) are present within cancer tissues. This suggests that tumors evolve from stem cells; however, the exact cell of tumor origin, the potential role of dedifferentiation, and the role of plasticity in tumor development are largely unknown. A model cancer for the study of the oncologic process is melanoma. The developmental biology of melanocytes is relatively well understood, the cells pigment as they differentiate making them easy to identify, and benign and malignant tumors develop on the skin surface allowing direct observation of growth features, early detection, and removal. This ready access to early-stage tumors will facilitate study of the early oncologic processes and the role of tissue stem cells. Melanomas, like other cancers, include a subpopulation of TSCs. These TSCs have access to embryologic developmental programs, including the capacity to differentiate along multiple cell lineages. For example, melanomas can activate germ–cell pathways with major implications for TSC self-renewal through the activation of telomerase and genomic instability through the collision of meiotic and mitotic pathways (meiomitosis). The TSC model is still evolving, but the existence of TSCs has significant ramifications for tumor development, diagnosis, prognosis, and treatment of melanoma and other cancers.Journal of Investigative Dermatology (2008) 128, 2365–2380; doi:10.1038/jid.2008.166
ACCESSION #
34251519

 

Related Articles

  • Germ Cell Proteins in Melanoma: Prognosis, Diagnosis, Treatment, and Theories on Expression. Rosa, Ashley M.; Dabas, Nitika; Byrnes, Diana M.; Eller, Mark S.; Grichnik, James M. // Journal of Skin Cancer;2012, p1 

    Germ cell protein expression in melanoma has been shown to correlate with malignancy, severity of disease and to serve as an immunologic target for therapy. However, very little is known about the role that germ cell proteins play in cancer development. Unique germ cell pathways include those...

  • Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications. Welker, P; Schadendorf, D; Artuc, M; Grabbe, J; Henz, B M // British Journal of Cancer;4/15/2000, Vol. 82 Issue 8, p1453 

    Stem cell factor (SCF), the ligand for c-Kit, is known to regulate developmental and functional processes of haematopoietic stem cells, mast cells and melanocytes. Two different splice variants form predominantly soluble (sSCF or SCF-1) and in addition some membrane-bound SCF (mSCF or SCF-2). In...

  • Does Melanoma Begin in a Melanocyte Stem Cell? Hoerter, James D.; Bradley, Patrick; Casillas, Alexandria; Chambers, Danielle; Weiswasser, Brandon; Clements, Lauren; Gilbert, Sarah; Jiao, Albert // Journal of Skin Cancer;2012, p1 

    What is the cellular origin of melanoma? What role do melanocyte stem cells (MSC) and other melanocyte precursors play in the development of melanoma? Are MSCs and other latent melanocyte precursors more susceptible to solar radiation? These and many other questions can be very effectively...

  • Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations. Mochel, Mark C.; Piris, Adriano; Nose, Vania; Hoang, Mai P. // American Journal of Clinical Pathology;2015, Vol. 143 Issue 6, p901 

    Objectives: Patients with heterozygous germline mutations in BRCA1-associated protein 1 (BAP1), a tumor suppressor gene, develop a tumor predisposition syndrome (OMIM 614327) with increased risk of uveal and cutaneous melanomas, cutaneous atypical and epithelioid melanocytic lesions, lung...

  • Vitamin D Metabolism and Effects on Pluripotency Genes and Cell Differentiation in Testicular Germ Cell Tumors In Vitro and In Vivo. Jensen, Martin Blomberg; Jørgensen, Anne; Nielsen, John Erik; Steinmeyer, Andreas; Leffers, Henrik; Juul, Anders; Rajpert-De Meyts, Ewa // Neoplasia;Oct2012, Vol. 14 Issue 10, p952 

    Testicular germ cell tumors (TGCTs) are classified as either seminomas or nonseminomas. Both tumors originate from carcinoma in situ (CIS) cells, which are derived from transformed fetal gonocytes. CIS, seminoma, and the undifferentiated embryonal carcinoma (EC) retain an embryonic phenotype and...

  • Loss of Oct-3/4 Expression in Embryonal Carcinoma Cells Is Associated with Induction of Cisplatin Resistance. Mueller, Thomas; Mueller, Lutz Peter; Luetzkendorf, Jana; Voigt, Wieland; Simon, Heike; Schmoll, Hans-Joachim // Tumor Biology;2006, Vol. 27 Issue 2, p71 

    Although the majority of testicular germ cell tumors (TGCTs) are curable by cisplatin-based chemotherapy, in a few cases, the occurrence of cisplatin resistance results in a poor outcome. The biological basis of this differential cisplatin sensitivity in TGCTs remains largely unexplained....

  • Gene expression profiling of rat spermatogonia and Sertoli cells reveals signaling pathways from stem cells to niche and testicular cancer cells to surrounding stroma. Ryser, Stephan; Glauser, Dominique; Vigier, Michelle; Yong Qiang Zhang; Tachini, Philippe; Schlegel, Werner; Durand, Philippe; Irminger-Finger, Irmgard // BMC Genomics;2011, Vol. 12 Issue 1, p1 

    Background: Stem cells and their niches are studied in many systems, but mammalian germ stem cells (GSC) and their niches are still poorly understood. In rat testis, spermatogonia and undifferentiated Sertoli cells proliferate before puberty, but at puberty most spermatogonia enter...

  • Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells. Giuliano, Caryl J.; Freemantle, Sarah J.; Spinella, Michael J. // Current Cancer Therapy Reviews;2006, Vol. 2 Issue 3, p255 

    Treatment of testicular germ cell tumors (TGCTs) has been a success primarily due to the exquisite responsiveness of this solid tumor to cisplatin-based therapy. Despite the promise of cure for the majority of TGCT patients, the effectiveness of therapy for some patients is limited by toxicity...

  • Determining fate. Greenwood, Emma // Nature Reviews Cancer;Jan2004, Vol. 4 Issue 1, p6 

    Discusses Sharon Gidekel and colleagues' report in "Cancer Cell" about the ability of OCT-3/4 transcription factor to determine the oncogenic potential of germ-cell tumours and could be useful as therapeutic agent. Role of OCT-3/4 in maintaining the stem-cell fate of germ cells; Increase in the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics